Giuseppe Testa, Head, Research Centre for Neurogenomics is one of the speakers of Wired health
On June 5th at 1:20 p.m. Professor Giuseppe Testa, Head, Research Centre for Neurogenomics, will be interviewed by Federico Ferrazza during Wired Health, the Wired event dedicated to health.
They will talk about the Lifetime 4 Covid project that also involves Human Technopole and the efforts of the scientific community to combat the Covid19 pandemic.
The interview will be live on: https://health2020.wired.it/
Share:
You could also like:
-
HT National Facilities: One Year On, New Call Open
On 10 June, Human Technopole marks the one-year anniversary of the official opening of its National Facilities, a key milestone in our mission to support excellence in life sciences across Italy. Celebrating this important date, we are pleased to announce that the new Call for Access to the National Facilities is now open. Researchers can submit their proposals until 30 September 2025.
-
10 Fully Funded PhD Scholarships in Systems Medicine through SEMM
Human Technopole is offering up to 10 fully funded PhD scholarships through the SEMM PhD Program in Systems Medicine. These scholarships are open to talented and motivated graduates—both from Italy and abroad – interested in pursuing doctoral research.
-
Human Technopole Commitment to Gender Equality
Human Technopole is proud to announce the launch of its new Gender Equality Plan (GEP) for 2025-2027, a strategic initiative designed to further integrate gender equality across all aspects of the Institute, building upon the successful outcomes of the previous GEP (2022-2024). HT has also achieved the UNI/PdR 125:2022 certification, which recognizes organizations that promote gender equality and foster inclusive workplaces.
-
2 fully funded PhD fellowships at HT through SISSA
Human Technopole is offering 2 fully funded 4-year PhD fellowships to young scientists from the national and international community who wish to undertake a doctoral degree on a project focused on Computational Biology.
-
Childhood Cancer: Free DNA in Blood Reveals Therapy Resistance
An international study coordinated by Milan’s Human Technopole, the Institute of Cancer Research (ICR) in London, and the Royal Marsden Hospital in London has shown that certain DNA fragments found in the blood of paediatric cancer patients can be used as “biomarkers” to obtain information on the characteristics of the disease and its ability to resist therapies. Analysing these fragments could represent an effective alternative to tumour tissue biopsy, a practice that is particularly difficult in children.